RxSight, Inc.
RXST
Rank in Stocks
#16609
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun... As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
Share Price
$4.86
Last synced: 2026-11-09
Market Cap
$202.14M
Change (1 day)
7.05%
Change (1 year)
-52.49%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade RxSight, Inc. (RXST)
Category
Healthcare
EPS for RxSight, Inc. (RXST)
EPS as of September 2026 TTM: $-1.28
According to RxSight, Inc.'s latest financial reports, its current EPS (TTM) is $-1.28. At the end of 2025 the company had an EPS of $-0.95, a decrease compared to its 2024 EPS of $-0.71.
EPS history for RxSight, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.28 | 34.74% |
| 2025 | $-0.95 | 33.80% |
| 2024 | $-0.71 | -49.65% |
| 2023 | $-1.41 | -41.49% |
| 2022 | $-2.41 | 35.39% |
| 2021 | $-1.78 | -1,088.89% |
| 2020 | $0.18 | -81.05% |
| 2019 | $0.95 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -310.94% |
US
|
|
| $4.09 | -419.53% |
IE
|
|
| $9.45 | -838.28% |
US
|
|
| $2.37 | -285.16% |
US
|
|
| $1.77 | -238.28% |
US
|
Questions about RxSight, Inc.'s earnings per share (EPS)
What is RxSight, Inc.'s earnings per share (EPS)?
RxSight, Inc.'s earnings per share (EPS) over the last twelve months is $-1.28, as of Sep 2026.
What was RxSight, Inc.'s earnings per share (EPS) in 2025?
In 2025, RxSight, Inc.'s earnings per share (EPS) was $-0.95, compared with $-0.71 in 2024.
How has RxSight, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, RxSight, Inc.'s earnings per share (EPS) was highest in 2020 ($0.18) and lowest in 2022 ($-2.41).
How does RxSight, Inc.'s earnings per share (EPS) compare with similar companies?
RxSight, Inc.'s earnings per share (EPS) ($-1.28) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.